Ana Aragon-Vinagre

San Sebastian, PV, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Neuropsychiatric Adverse Events Associated With Foslevodopa/Foscarbidopa Continuous Subcutaneous Infusion in Clinical Practice: A Multicenter Study.

Neuropsychiatric Adverse Events Associated With Foslevodopa/Foscarbidopa Continuous Subcutaneous Infusion in Clinical Practice: A Multicenter Study.

Journal: European journal of neurology
Published: March 30, 2026

In-depth mass-spectrometry reveals phospho-RAB12 as a blood biomarker of G2019S LRRK2-driven Parkinson's disease.

In-depth mass-spectrometry reveals phospho-RAB12 as a blood biomarker of G2019S LRRK2-driven Parkinson's disease.

Journal: Brain : a journal of neurology
Published: June 13, 2024

Gut Microbial Metabolites and Future Risk of Parkinson's Disease: A Metabolome-Wide Association Study.

Gut Microbial Metabolites and Future Risk of Parkinson's Disease: A Metabolome-Wide Association Study.

Journal: Movement disorders : official journal of the Movement Disorder Society
Published: May 28, 2024

Prediagnostic Blood Metal Levels and the Risk of Parkinson's Disease: A Large European Prospective Cohort.

Prediagnostic Blood Metal Levels and the Risk of Parkinson's Disease: A Large European Prospective Cohort.

Journal: Movement disorders : official journal of the Movement Disorder Society
Published: May 26, 2023

Elevated urine BMP phospholipids in LRRK2 and VPS35 mutation carriers with and without Parkinson's disease.

Elevated urine BMP phospholipids in LRRK2 and VPS35 mutation carriers with and without Parkinson's disease.

Journal: NPJ Parkinson's disease
Published: November 22, 2022

A Set of Reliable Samples for the Study of Biomarkers for the Early Diagnosis of Parkinson's Disease.

A Set of Reliable Samples for the Study of Biomarkers for the Early Diagnosis of Parkinson's Disease.

Journal: Frontiers in neurology
Published: December 28, 2021

Opicapone for the treatment of Parkinson's disease: real-life data in Spain

Opicapone for the treatment of Parkinson's disease: real-life data in Spain

Journal: Revista de neurologia
Published: December 13, 2021

R1441G but not G2019S mutation enhances LRRK2 mediated Rab10 phosphorylation in human peripheral blood neutrophils.

R1441G but not G2019S mutation enhances LRRK2 mediated Rab10 phosphorylation in human peripheral blood neutrophils.

Journal: Acta neuropathologica
Published: January 28, 2021

Management of an outbreak of botulism with benign clinical presentation.

Management of an outbreak of botulism with benign clinical presentation.

Journal: Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
Published: December 06, 2020

A More Homogeneous Phenotype in Parkinson's Disease Related to R1441G Mutation in the LRRK2 Gene.

A More Homogeneous Phenotype in Parkinson's Disease Related to R1441G Mutation in the LRRK2 Gene.

Journal: Frontiers in neurology
Published: November 30, 2020

Clinical utility of a personalized and long-term monitoring device for Parkinson's disease in a real clinical practice setting: An expert opinion survey on STAT-ON™.

Clinical utility of a personalized and long-term monitoring device for Parkinson's disease in a real clinical practice setting: An expert opinion survey on STAT-ON™.

Journal: Neurologia
Published: August 06, 2020

Clinical utility of a personalized and long-term monitoring device for Parkinson's disease in a real clinical practice setting: An expert opinion survey on STAT-ON™.

Clinical utility of a personalized and long-term monitoring device for Parkinson's disease in a real clinical practice setting: An expert opinion survey on STAT-ON™.

Journal: Neurologia
Published: August 06, 2020
Showing 1-12 of 13

Last Updated: 09/26/2026